Mutations in ABCA7 in a Belgian cohort of Alzheimer's disease patients: a targeted resequencing study
Abstract
Background ABCA7 was identified as a risk gene for Alzheimer's disease in genome-wide association studies (GWAS). It was one of the genes most strongly associated with risk of Alzheimer's disease in a Belgian cohort. Using targeted resequencing, we investigated ABCA7 in this cohort with the aim to directly detect rare and common variations in this gene associated with Alzheimer's disease pathogenesis. Methods We did massive parallel resequencing of ABCA7 after HaloPlex target enrichment of the exons, introns, and regulatory regions in 772 unrelated patients with Alzheimer's disease (mean age at onset 74·6 years [SD 8·9]) recruited at two memory clinics in Flanders, Belgium, and 757 geographically matched community-dwelling controls (mean age at inclusion 73·9 years [8·0]). After bioinformatic processing, common variants were analysed with conditional logistic regression and rare variant association analysis was done in Variant Association Tools. To explore an observed founder effect, additional unrelated patients with Alzheimer's disease (n=183, mean age at onset 78·8 years [SD 6·0]) and control individuals (n=265, mean age at inclusion 56·9 years [10·8]) from the same cohort who had not been included in massive parallel resequencing because of insufficient biosamples were screened for the ABCA7 frameshift mutation Glu709fs with Sanger sequencing. The effect of loss-of-function mutations on ABCA7 expression was investigated with quantitative real-time PCR in post-mortem brains of patients (n=3) and control individuals (n=4); nonsense mediated mRNA decay was investigated in lymphoblast cell lines from three predicted loss-of-function mutation carriers from the cohort of 772 patients with Alzheimer's disease. Findings An intronic low-frequency variant rs78117248 (minor allele frequency 3·8% in 58 patients with Alzheimer's disease and in controls 1·8% in 28 controls) showed strongest association with Alzheimer's disease (odds ratio 2·07, 95% CI 1·31-3·27; p=0·0016), and remained significant after conditioning for the GWAS top single nucleotide polymorphisms rs3764650, rs4147929, and rs3752246 (2·00, 1·22-3·26; p=0·006). We identified an increased frequency of predicted loss-of-function mutations in the patients compared with the controls (relative risk 4·03, 95% CI 1·75-9·29; p=0·0002). One frameshift mutation (Glu709fs) showed a founder effect in the study population, and was found to segregate with disease in a family with autosomal dominant inheritance of Alzheimer's disease. Expression of ABCA7 was reduced in the two carriers of loss-of-function mutations found only in patients with Alzheimer's disease (Glu709fs and Trp1214*) compared with four non-carrier controls (relative expression 0·45, 95% CI 0·25-0·84; p=0·002) and in lymphoblast cell lines from three carriers of Glu709fs compared with those from two non-carrier controls. Interpretation We propose that a low-frequency variant can explain the association between ABCA7 and Alzheimer's disease, and the evidence of loss-of-function mutations in this risk gene suggests that partial loss-of-function of ABCA7 could be a potential pathogenetic mechanism of Alzheimer's disease. Funding Belgian Science Policy Office Interuniversity Attraction Poles program P7/16, Alzheimer Research Foundation, King Baudouin Foundation AB Fund, Methusalem Excellence Program initiative of the Flemish Government, Flanders Impulse Program on Networks for Dementia Research, Research Foundation Flanders, Agency for Innovation by Science and Technology Flanders, University of Antwerp Research Fund, and European Union's Seventh Framework Programme for Research, Technological development and Demonstration (AgedBrainSYSBIO).
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Loss-of-function mutations in ABCA7 have been identified as associated with Alzheimer's disease risk in European populations.
“loss-of-function mutations in ABCA7 have been identified as associated with disease risk in European populations [104–106]”
From Genetic architecture of Alzheimer's disease (2020) · cites this paper as [105]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
Folstein, M. F., Folstein, S. E., & McHugh, P. R. (1975) · Journal of Psychiatric Research · doi:10.1016/0022-3956(75)90026-6 · Cited by 88,282 · see citing works
PLINK: a tool set for whole-genome association and population-based linkage analyses.
Purcell, S., Neale, B., Todd-Brown, K., Thomas, L., Ferreira, M. A. R., Bender, D., Maller, J., Sklar, P., de Bakker, P. I. W., Daly, M. J., et al. (2007) · The American Journal of Human Genetics · doi:10.1086/519795 · Cited by 34,089 · see citing works
McKhann, G., Drachman, D., Folstein, M., Katzman, R., Price, D., & Stadlan, E. M. (1984) · Neurology · doi:10.1212/wnl.34.7.939 · Cited by 27,915 · see citing works
McKhann, G. M., Knopman, D. S., Chertkow, H., Hyman, B. T., Jack, C. R., Kawas, C. H., Klunk, W. E., Koroshetz, W. J., Manly, J. J., Mayeux, R., et al. (2011) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2011.03.005 · Cited by 18,657 · see citing works
Meta-Analysis of 74,046 Individuals Identifies 11 New Susceptibility Loci for Alzheimer’s Disease
(EADI), E. A. D. I., Lambert, J.-C., (GERAD), G. A. E. R. I. A. D., Alzheimer's Disease Genetic Consortium (ADGC), (CHARGE), C. F. H. A. A. R. I. G. E., Ibrahim-Verbaas, C. A., Harold, D., Naj, A. C., Sims, R., Bellenguez, C., et al. (2013) · Nature Genetics · doi:10.1038/ng.2802 · Cited by 4,336 · see citing works
Self-citationHarold, D., Abraham, R., Hollingworth, P., Sims, R., Gerrish, A., Hamshere, M. L., Pahwa, J. S., Moskvina, V., Dowzell, K., Williams, A., et al. (2009) · Nature Genetics · doi:10.1038/ng.440 · Cited by 3,326 · see citing works
Self-citationHyman, B. T., Phelps, C. H., Beach, T. G., Bigio, E. H., Cairns, N. J., Carrillo, M. C., Dickson, D. W., Duyckaerts, C., Frosch, M. P., Masliah, E., et al. (2012) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2011.10.007 · Cited by 3,092 · see citing works
Genome-wide association studies for common diseases and complex traits
Hirschhorn, J. N., & Daly, M. J. (2005) · Nature Reviews Genetics · doi:10.1038/nrg1521 · Cited by 2,853 · see citing works
Annotation of functional variation in personal genomes using RegulomeDB
Boyle, A. P., Hong, E. L., Hariharan, M., Cheng, Y., Schaub, M. A., Kasowski, M., Karczewski, K. J., Park, J., Hitz, B. C., Weng, S., et al. (2012) · Genome Research · doi:10.1101/gr.137323.112 · Cited by 2,722 · see citing works
Genome-wide association study identifies variants at CLU and CR1 associated with Alzheimer's disease
the European Alzheimer's Disease Initiative Investigators, Lambert, J.-C., Heath, S., Even, G., Campion, D., Sleegers, K., Hiltunen, M., Combarros, O., Zelenika, D., Bullido, M. J., et al. (2009) · Nature Genetics · doi:10.1038/ng.439 · Cited by 2,234 · see citing works
Self-citationInitiative, T. A. D. N., Hollingworth, P., CHARGE consortium, EADI1 consortium, Harold, D., Sims, R., Gerrish, A., Lambert, J.-C., Carrasquillo, M. M., Abraham, R., et al. (2011) · Nature Genetics · doi:10.1038/ng.803 · Cited by 1,997 · see citing works
Self-citationNaj, A. C., Jun, G., Beecham, G. W., Wang, L.-S., Vardarajan, B. N., Buros, J., Gallins, P. J., Buxbaum, J. D., Jarvik, G. P., Crane, P. K., et al. (2011) · Nature Genetics · doi:10.1038/ng.801 · Cited by 1,901 · see citing works
Genome-wide Analysis of Genetic Loci Associated With Alzheimer Disease
Seshadri, S. (2010) · JAMA · doi:10.1001/jama.2010.574 · Cited by 1,219 · see citing works
Rare-Variant Association Analysis: Study Designs and Statistical Tests
Lee, S., Abecasis, G. R., Boehnke, M., & Lin, X. (2014) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2014.06.009 · Cited by 1,042 · see citing works
Structural diversity of ABC transporters
ter Beek, J., Guskov, A., & Slotboom, D. J. (2014) · The Journal of General Physiology · doi:10.1085/jgp.201411164 · Cited by 384 · see citing works
Loss-of-function variants in ABCA7 confer risk of Alzheimer's disease
DemGene, Steinberg, S., Stefansson, H., Jonsson, T., Johannsdottir, H., Ingason, A., Helgason, H., Sulem, P., Magnusson, O. T., Gudjonsson, S. A., et al. (2015) · Nature Genetics · doi:10.1038/ng.3246 · Cited by 324 · see citing works
Frackowiak, J., Wisniewski, H. M., Wegiel, J., Merz, G. S., Iqbal, K., & Wang, K. C. (1992) · Acta Neuropathologica · doi:10.1007/bf00227813 · Cited by 276 · see citing works
Jehle, A. W., Gardai, S. J., Li, S., Linsel‐Nitschke, P., Morimoto, K., Janssen, W. J., Vandivier, R. W., Wang, N., Greenberg, S., Dale, B. M., et al. (2006) · The Journal of Cell Biology · doi:10.1083/jcb.200601030 · Cited by 213 · see citing works
Chung, H., Brazil, M. I., Soe, T. T., & Maxfield, F. R. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.45.32301 · Cited by 212 · see citing works
Kim, W. S., Li, H., Ruberu, K. R., Chan, S. L., Elliott, D. A., Low, J. K., Cheng, D., Karl, T., & Garner, B. (2013) · Journal of Neuroscience · doi:10.1523/jneurosci.4165-12.2013 · Cited by 208 · see citing works
Cuyvers, E., Bettens, K., Philtjens, S., Langenhove, T. V., Gijselinck, I., van der Zee, J., Engelborghs, S., Vandenbulcke, M., Dongen, J. V., Geerts, N., et al. (2014) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2013.09.009 · Cited by 191 · see citing works
Self-citationNovel late-onset Alzheimer disease loci variants associate with brain gene expression
Allen, M., Zou, F., Chai, H. S., Younkin, C. S., Crook, J. E., Pankratz, V. S., Carrasquillo, M. M., Rowley, C. N., Nair, A., Middha, S., et al. (2012) · Neurology · doi:10.1212/wnl.0b013e3182605801 · Cited by 164 · see citing works
Kim, W., Guillemin, G., Glaros, E., Lim, C. K., & Garner, B. (2006) · NeuroReport · doi:10.1097/01.wnr.0000221833.41340.cd · Cited by 158 · see citing works
ATP‐binding cassette transporter A7 regulates processing of amyloid precursor protein in vitro
Chan, S. L., Kim, W. S., Kwok, J. B., Hill, A. F., Cappai, R., Rye, K., & Garner, B. (2008) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2008.05433.x · Cited by 133 · see citing works
Sleegers, K., Bettens, K., De Roeck, A., Van Cauwenberghe, C., Cuyvers, E., Verheijen, J., Struyfs, H., Van Dongen, J., Vermeulen, S., Engelborghs, S., et al. (2015) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2015.02.013 · Cited by 106 · see citing works
Self-citationABCA7 expression is associated with Alzheimer's disease polymorphism and disease status
Vasquez, J. B., Fardo, D. W., & Estus, S. (2013) · Neuroscience Letters · doi:10.1016/j.neulet.2013.09.058 · Cited by 101 · see citing works
Bettens, K., Brouwers, N., Engelborghs, S., Lambert, J., Rogaeva, E. A., Vandenberghe, R. R., Bastard, N. L., Pasquier, F., Vermeulen, S., Dongen, J. V., et al. (2012) · Molecular Neurodegeneration · doi:10.1186/1750-1326-7-3 · Cited by 94 · see citing works
Self-citationABC proteins: key molecules for lipid homeostasis
Takahashi, K., Kimura, Y., Nagata, K., Yamamoto, A., Matsuo, M., & Ueda, K. (2005) · Medical Molecular Morphology · doi:10.1007/s00795-004-0278-8 · Cited by 94 · see citing works
Wang, G. T., Peng, B., & Leal, S. M. (2014) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2014.04.004 · Cited by 75 · see citing works
Context Effects on Misreading and Suppression at UAG Codons in Human Cells
Phillips‐Jones, M. K., Hill, L. S. J., Atkinson, J., & Martin, R. (1995) · Molecular and Cellular Biology · doi:10.1128/mcb.15.12.6593 · Cited by 63 · see citing works
SQSTM1 mutations in Han Chinese populations with sporadic amyotrophic lateral sclerosis
Chen, Y., Zheng, Z., Chen, X., Huang, R., Yang, Y., Yuan, L., Pan, L., Hadano, S., & Shang, H. (2013) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2013.09.008 · Cited by 60 · see citing works
Nonsense-mediated mRNA decay of collagen – emerging complexity in RNA surveillance mechanisms
Fang, Y., Bateman, J. F., Mercer, J. F. B., & Lamandé, S. R. (2013) · Journal of Cell Science · doi:10.1242/jcs.120220 · Cited by 37 · see citing works
An evaluation of the mechanism of ABCA7 on cellular lipid release in ABCA7-HEC293 cell
Chengai, W., Wang, N., & Dan-hui, Z. H. A. O. (2013) · Chinese Medical Journal · doi:10.3760/cma.j.issn.0366-6999.20123502 · Cited by 5 · see citing works
Flagged first, then by citations
1 of the 34 references couldn’t be matched to a known paper.
Cited by
Sorted by citations
Scheltens, P., De Strooper, B., Kivipelto, M., Holstege, H., Chételat, G., Teunissen, C. E., Cummings, J., & van der Flier, W. M. (2021) · The Lancet · doi:10.1016/s0140-6736(20)32205-4 · Cited by 5,465 · see citing works
The genetic landscape of Alzheimer disease: clinical implications and perspectives
Van Cauwenberghe, C., Van Broeckhoven, C., & Sleegers, K. (2016) · Genetics in Medicine · doi:10.1038/gim.2015.117 · Cited by 863 · see citing works
Self-citationMolecular genetics of early-onset Alzheimer’s disease revisited
Cacace, R., Sleegers, K., & Van Broeckhoven, C. (2016) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2016.01.012 · Cited by 617 · see citing works
Self-citationLate onset Alzheimer’s disease genetics implicates microglial pathways in disease risk
Efthymiou, A. G., & Goate, A. M. (2017) · Molecular Neurodegeneration · doi:10.1186/s13024-017-0184-x · Cited by 562 · see citing works
Bisht, K., Sharma, K. P., & Tremblay, M. (2018) · Neurobiology of Stress · doi:10.1016/j.ynstr.2018.05.003 · Cited by 351 · see citing works
Cuyvers, E., & Sleegers, K. (2016) · The Lancet Neurology · doi:10.1016/s1474-4422(16)00127-7 · Cited by 284 · see citing works
Self-citationBis, J. C., Jian, X., Kunkle, B. W., Chen, Y., Hamilton-Nelson, K. L., Bush, W. S., Salerno, W. J., Lancour, D., Ma, Y., Renton, A. E., et al. (2020) · Molecular Psychiatry · doi:10.1038/s41380-018-0112-7 · Cited by 248 · see citing works
Genetics of Alzheimer’s disease: where we are, and where we are going
Bellenguez, C., Grenier-Boley, B., & Lambert, J.-C. (2020) · Current Opinion in Neurobiology · doi:10.1016/j.conb.2019.11.024 · Cited by 215 · see citing works
Holstege, H., Hulsman, M., Charbonnier, C., Grenier-Boley, B., Quenez, O., Grozeva, D., van Rooij, J. G. J., Sims, R., Ahmad, S., Amin, N., et al. (2022) · Nature Genetics · doi:10.1038/s41588-022-01208-7 · Cited by 226 · see citing works
Untangling Genetic Risk for Alzheimer’s Disease
Pimenova, A. A., Raj, T., & Goate, A. M. (2018) · Biological Psychiatry · doi:10.1016/j.biopsych.2017.05.014 · Cited by 223 · see citing works
The role of ABCA7 in Alzheimer’s disease: evidence from genomics, transcriptomics and methylomics
De Roeck, A., Van Broeckhoven, C., & Sleegers, K. (2019) · Acta Neuropathologica · doi:10.1007/s00401-019-01994-1 · Cited by 212 · see citing works
Self-citationUnderstanding Alzheimer Disease at the Interface between Genetics and Transcriptomics
Verheijen, J., & Sleegers, K. (2018) · Trends in Genetics · doi:10.1016/j.tig.2018.02.007 · Cited by 189 · see citing works
Self-citationBellenguez, C., Charbonnier, C., Grenier-Boley, B., Quenez, O., Le Guennec, K., Nicolas, G., Chauhan, G., Wallon, D., Rousseau, S., Richard, A. C., et al. (2017) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2017.07.001 · Cited by 166 · see citing works
A global view of the genetic basis of Alzheimer disease
Reitz, C., Pericak-Vance, M., Foroud, T., & Mayeux, R. (2023) · Nature Reviews Neurology · doi:10.1038/s41582-023-00789-z · Cited by 143 · see citing works
Unique roles of rare variants in the genetics of complex diseases in humans
Momozawa, Y., & Mizukami, K. (2021) · Journal of Human Genetics · doi:10.1038/s10038-020-00845-2 · Cited by 161 · see citing works
ABCA7 Deficiency Accelerates Amyloid-β Generation and Alzheimer's Neuronal Pathology
Sakae, N., Liu, C., Shinohara, M., Frisch‐Daiello, J. L., Ma, L., Yamazaki, Y., Tachibana, M., Younkin, L. H., Kurti, A., Carrasquillo, M. M., et al. (2016) · Journal of Neuroscience · doi:10.1523/jneurosci.3757-15.2016 · Cited by 146 · see citing works
The genetic landscape of Alzheimer disease
Carmona, S., Hardy, J., & Guerreiro, R. J. (2018) · Handbook of clinical neurology · doi:10.1016/b978-0-444-64076-5.00026-0 · Cited by 133 · see citing works
Genetic analyses of early-onset Alzheimer’s disease using next generation sequencing
Giau, V. V., Bagyinszky, E., Yang, Y. S., Youn, Y. C., An, S. S. A., & Kim, S. (2019) · Scientific Reports · doi:10.1038/s41598-019-44848-2 · Cited by 133 · see citing works
ATP-binding cassette transporter A7 (ABCA7) loss of function alters Alzheimer amyloid processing
Satoh, K., Abe-Dohmae, S., Yokoyama, S., St George-Hyslop, P., & Fraser, P. E. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.655076 · Cited by 128 · see citing works
Neurodegeneration and Neuro-Regeneration—Alzheimer’s Disease and Stem Cell Therapy
Vasić, V., Barth, K., & Schmidt, M. H. H. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20174272 · Cited by 128 · see citing works
Genetic architecture of Alzheimer's disease
Neuner, S. M., TCW, J., & Goate, A. M. (2020) · Neurobiology of Disease · doi:10.1016/j.nbd.2020.104976 · Cited by 126 · see citing works
ABCA7 and Pathogenic Pathways of Alzheimer’s Disease
Aikawa, T., Holm, M., & Kanekiyo, T. (2018) · Brain Sciences · doi:10.3390/brainsci8020027 · Cited by 124 · see citing works
Campion, D., Charbonnier, C., & Nicolas, G. (2019) · Acta Neuropathologica · doi:10.1007/s00401-019-01991-4 · Cited by 124 · see citing works
Alzheimer's Disease Mechanisms and Emerging Roads to Novel Therapeutics
Sala Frigerio, C., & De Strooper, B. (2016) · Annual Review of Neuroscience · doi:10.1146/annurev-neuro-070815-014015 · Cited by 116 · see citing works
Verheijen, J., Van den Bossche, T., van der Zee, J., Engelborghs, S., Sanchez-Valle, R., Lladó, A., Graff, C., Thonberg, H., Pastor, P., Ortega-Cubero, S., et al. (2016) · Acta Neuropathologica · doi:10.1007/s00401-016-1566-9 · Cited by 112 · see citing works
Self-citationHoogmartens, J., Cacace, R., & Broeckhoven, C. V. (2021) · Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring · doi:10.1002/dad2.12155 · Cited by 101 · see citing works
Genome–microbiome interplay provides insight into the determinants of the human blood metabolome
Diener, C., Dai, C. L., Wilmanski, T., Baloni, P., Smith, B., Rappaport, N., Hood, L., Magis, A. T., & Gibbons, S. M. (2022) · Nature Metabolism · doi:10.1038/s42255-022-00670-1 · Cited by 102 · see citing works
<i>ABCA7</i> frameshift deletion associated with Alzheimer disease in African Americans
Cukier, H. N., Kunkle, B. W., Vardarajan, B. N., Rolati, S., Hamilton-Nelson, K. L., Kohli, M. A., Whitehead, P. L., Dombroski, B. A., Van Booven, D., Lang, R., et al. (2016) · Neurology Genetics · doi:10.1212/nxg.0000000000000079 · Cited by 100 · see citing works
ABCA7 Mediates Phagocytic Clearance of Amyloid-β in the Brain
Fu, Y., Hsiao, J.-H. T., Paxinos, G., Halliday, G. M., & Kim, W. S. (2016) · Journal of Alzheimer s Disease · doi:10.3233/jad-160456 · Cited by 98 · see citing works
17q21.31 duplication causes prominent tau-related dementia with increased MAPT expression
Guennec, K. L., Quenez, O., Nicolas, G., Wallon, D., Rousseau, S., Richard, A.-C., Alexander, J., Paschou, P., Charbonnier, C., Bellenguez, C., et al. (2016) · Molecular Psychiatry · doi:10.1038/mp.2016.226 · Cited by 96 · see citing works
An intronic VNTR affects splicing of ABCA7 and increases risk of Alzheimer’s disease
On Behalf of the BELNEU Consortium, De Roeck, A., Duchateau, L., Van Dongen, J., Cacace, R., Bjerke, M., Van den Bossche, T., Cras, P., Vandenberghe, R., De Deyn, P. P., et al. (2018) · Acta Neuropathologica · doi:10.1007/s00401-018-1841-z · Cited by 93 · see citing works
Self-citationShifting paradigms: The central role of microglia in Alzheimer’s disease
Schwabe, T., Srinivasan, K., & Rhinn, H. (2020) · Neurobiology of Disease · doi:10.1016/j.nbd.2020.104962 · Cited by 84 · see citing works
Semba, R. D. (2020) · Advances in Nutrition · doi:10.1093/advances/nmaa024 · Cited by 79 · see citing works
Deleterious ABCA7 mutations and transcript rescue mechanisms in early onset Alzheimer’s disease
On behalf of the European Early-Onset Dementia (EU EOD) consortium, De Roeck, A., Van den Bossche, T., van der Zee, J., Verheijen, J., De Coster, W., Van Dongen, J., Dillen, L., Baradaran-Heravi, Y., Heeman, B., et al. (2017) · Acta Neuropathologica · doi:10.1007/s00401-017-1714-x · Cited by 74 · see citing works
Self-citationNitta, Y., & Sugie, A. (2022) · Fly · doi:10.1080/19336934.2022.2087484 · Cited by 74 · see citing works
The Role of Genetics in Advancing Precision Medicine for Alzheimer’s Disease—A Narrative Review
Freudenberg‐Hua, Y., Li, W., & Davies, P. (2018) · Frontiers in Medicine · doi:10.3389/fmed.2018.00108 · Cited by 74 · see citing works
<i>ABCA7</i> rare variants and Alzheimer disease risk
Le Guennec, K., Nicolas, G., Quenez, O., Charbonnier, C., Wallon, D., Bellenguez, C., Grenier-Boley, B., Rousseau, S., Richard, A.-C., Rovelet-Lecrux, A., et al. (2016) · Neurology · doi:10.1212/wnl.0000000000002627 · Cited by 69 · see citing works
Genetics of Alzheimer's Disease
Kim, J. H. (2018) · Dementia and Neurocognitive Disorders · doi:10.12779/dnd.2018.17.4.131 · Cited by 67 · see citing works
Intracellular Trafficking Mechanisms of Synaptic Dysfunction in Alzheimer’s Disease
Perdigão, C., Barata, M. A., Araújo, M. N., Mirfakhar, F., Castanheira, J., & Almeida, C. G. (2020) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2020.00072 · Cited by 56 · see citing works
Martiskainen, H., Herukka, S., Stančáková, A., Paananen, J., Soininen, H., Kuusisto, J., Laakso, M., & Hiltunen, M. (2017) · Annals of Neurology · doi:10.1002/ana.24969 · Cited by 64 · see citing works
rs34331204 regulates TSPAN13 expression and contributes to Alzheimer’s disease with sex differences
Hu, Y., Zhang, H., Liu, B., Gao, S., Wang, T., Han, Z., International Genomics of Alzheimer’s Project (IGAP), Ji, X., & Liu, G. (2020) · Brain · doi:10.1093/brain/awaa302 · Cited by 62 · see citing works
Strunz, T., Lauwen, S., Kiel, C., International AMD Genomics Consortium (IAMDGC), Fritsche, L. G., Igl, W., Bailey, J. N. C., Grassmann, F., Sengupta, S., Bragg-Gresham, J. L., et al. (2020) · Scientific Reports · doi:10.1038/s41598-020-58510-9 · Cited by 60 · see citing works
Genetics of Alzheimer’s disease: From pathogenesis to clinical usage
Shao, W., Peng, D., & Wang, X. (2017) · Journal of Clinical Neuroscience · doi:10.1016/j.jocn.2017.06.074 · Cited by 61 · see citing works
The role of ATP-binding cassette subfamily A in the etiology of Alzheimer’s disease
Bossaerts, L., Cacace, R., & van Broeckhoven, C. (2022) · Molecular Neurodegeneration · doi:10.1186/s13024-022-00536-w · Cited by 50 · see citing works
ABCA7 p.G215S as potential protective factor for Alzheimer's disease
Sassi, C., Nalls, M. A., Ridge, P. G., Gibbs, J. R., Ding, J., Lupton, M. K., Troakes, C., Lunnon, K., Al‐Sarraj, S., Brown, K. S., et al. (2016) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2016.04.004 · Cited by 55 · see citing works
Clinico-genetic findings in 509 frontotemporal dementia patients
Wagner, M., Lorenz, G., Volk, A. E., Brunet, T., Edbauer, D., Berutti, R., Zhao, C., Anderl‐Straub, S., Bertram, L., Danek, A., et al. (2021) · Molecular Psychiatry · doi:10.1038/s41380-021-01271-2 · Cited by 61 · see citing works
From Common to Rare Variants: The Genetic Component of Alzheimer Disease
Nicolas, G., Charbonnier, C., & Campion, D. (2016) · Human Heredity · doi:10.1159/000452256 · Cited by 47 · see citing works
Lysophosphatidylcholine export by human ABCA7.
Tomioka, M., Toda, Y., Mañucat, N. B., Akatsu, H., Fukumoto, M., Kono, N., Arai, H., Kioka, N., & Ueda, K. (2017) · Biochimica et Biophysica Acta - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2017.03.012 · Cited by 49 · see citing works
Molecular Genetics of Early- and Late-Onset Alzheimer’s Disease
Uddin, M. S., Hasana, S., Hossain, M. F., Islam, M. S., Behl, T., Perveen, A., Hafeez, A., & Ashraf, G. M. (2020) · Current Gene Therapy · doi:10.2174/1566523220666201123112822 · Cited by 53 · see citing works
The impact of rare genetic variants on Alzheimer disease
Deyn, L. D., & Sleegers, K. (2025) · Nature Reviews Neurology · doi:10.1038/s41582-025-01062-1 · Cited by 43 · see citing works
Self-citationKou, I., Watanabe, K., Takahashi, Y., Momozawa, Y., Khanshour, A. M., Grauers, A., Zhou, H., Liu, G., Fan, Y., Takeda, K., et al. (2018) · Scientific Reports · doi:10.1038/s41598-018-29011-7 · Cited by 42 · see citing works
Gao, C., Shen, X., Tan, Y., & Chen, S. (2022) · Journal of Neuroinflammation · doi:10.1186/s12974-022-02580-1 · Cited by 43 · see citing works
INPP5D mRNA Expression and Cognitive Decline in Japanese Alzheimer’s Disease Subjects
Yoshino, Y., Yamazaki, K., Ozaki, Y., Sao, T., Yoshida, T., Mori, T., Mori, Y., Ochi, S., Iga, J.-I., & Ueno, S.-I. (2017) · Journal of Alzheimer's Disease · doi:10.3233/jad-161211 · Cited by 41 · see citing works
A neurodegenerative disease landscape of rare mutations in Colombia due to founder effects
Acosta‐Uribe, J., Aguillon, D. F., Cochran, J. N., Giraldo, M., Madrigal, L., Killingsworth, B. W., Singhal, R., Labib, S., Alzate, D., Velilla, L. M., et al. (2022) · Genome Medicine · doi:10.1186/s13073-022-01035-9 · Cited by 40 · see citing works
Nous, A., Seynaeve, L., Feys, O., Wens, V., Tiège, X. D., van Mierlo, P., Baroumand, A. G., Nieboer, K., Allemeersch, G., Mangelschots, S., et al. (2024) · Alzheimer s Research & Therapy · doi:10.1186/s13195-023-01373-9 · Cited by 40 · see citing works
Self-citationEmerging genetic complexity and rare genetic variants in neurodegenerative brain diseases
Perrone, F., Cacace, R., van der Zee, J., & Broeckhoven, C. V. (2021) · Genome Medicine · doi:10.1186/s13073-021-00878-y · Cited by 37 · see citing works
Overlap between Parkinson disease and Alzheimer disease in ABCA7 functional variants
Nuytemans, K., Maldonado, L. G., Ali, A., John‐Williams, K., Beecham, G. W., Martin, E. R., Scott, W. K., & Vance, J. M. (2016) · Neurology Genetics · doi:10.1212/nxg.0000000000000044 · Cited by 37 · see citing works
ABCA7 loss-of-function variants, expression, and neurologic disease risk
Allen, M., Lincoln, S., Corda, M., Watzlawik, J. O., Carrasquillo, M. M., Reddy, J. S., Burgess, J. D., Nguyen, T., Malphrus, K. G., Petersen, R. C., et al. (2017) · Neurology Genetics · doi:10.1212/nxg.0000000000000126 · Cited by 37 · see citing works
Targeted Sequencing of Alzheimer Disease Genes in African Americans Implicates Novel Risk Variants
Logue, M. W., Lancour, D., Farrell, J. J., Simkina, I., Fallin, M. D., Lunetta, K. L., & Farrer, L. A. (2018) · Frontiers in Neuroscience · doi:10.3389/fnins.2018.00592 · Cited by 37 · see citing works
The ABC's of Alzheimer risk gene ABCA7
Duchateau, L., Wawrzyniak, N., & Sleegers, K. (2024) · Alzheimer s & Dementia · doi:10.1002/alz.13805 · Cited by 33 · see citing works
Self-citationAfrican American exome sequencing identifies potential risk variants at Alzheimer disease loci
N’Songo, A., Carrasquillo, M. M., Wang, X., Burgess, J. D., Nguyen, T., Asmann, Y. W., Serie, D., Younkin, S. G., Allen, M., Pedraza, O., et al. (2017) · Neurology Genetics · doi:10.1212/nxg.0000000000000141 · Cited by 36 · see citing works
New Insights into the Molecular Bases of Familial Alzheimer’s Disease
D’Argenio, V., & Sarnataro, D. (2020) · Journal of Personalized Medicine · doi:10.3390/jpm10020026 · Cited by 35 · see citing works
Relation between plasma and brain lipids
Wellington, C. L., & Frikke-Schmidt, R. (2016) · Current Opinion in Lipidology · doi:10.1097/mol.0000000000000291 · Cited by 33 · see citing works
Phenotypic characteristics of Alzheimer patients carrying an ABCA7 mutation
den Bossche, T. V., Sleegers, K., Cuyvers, E., Engelborghs, S., Sieben, A., Roeck, A. D., Cauwenberghe, C. V., Vermeulen, S., den Broeck, M. V., Laureys, A., et al. (2016) · Neurology · doi:10.1212/wnl.0000000000002628 · Cited by 33 · see citing works
Self-citationCryo‐EM structures of human ABCA7 provide insights into its phospholipid translocation mechanisms
Le, L. T. M., Thompson, J. R., Dehghani‐Ghahnaviyeh, S., Pant, S., Dang, P. X., French, J. B., Kanikeyo, T., Tajkhorshid, E., & Alam, A. (2023) · The EMBO Journal · doi:10.15252/embj.2022111065 · Cited by 31 · see citing works
Biallelic Loss of Function of SORL1 in an Early Onset Alzheimer’s Disease Patient
Guennec, K. L., Tubeuf, H., Hannequin, D., Wallon, D., Quenez, O., Rousseau, S., Richard, A., Deleuze, J., Boland, A., Frébourg, T., et al. (2018) · Journal of Alzheimer s Disease · doi:10.3233/jad-170981 · Cited by 29 · see citing works
Lee, W., Choi, S. H., Shea, M. G., Cheng, P., Dombroski, B. A., Pitsillides, A., Heard‐Costa, N. L., Wang, H., Bulekova, K., Kuzma, A. B., et al. (2024) · Alzheimer s & Dementia · doi:10.1002/alz.14283 · Cited by 27 · see citing works
Association of rare variants in neurodegenerative genes with familial Alzheimer’s disease
Zhang, W., Jiao, B., Xiao, T., Liu, X., Liao, X., Xiao, X., Guo, L., Yuan, Z., Yan, X., Tang, B., et al. (2020) · Annals of Clinical and Translational Neurology · doi:10.1002/acn3.51197 · Cited by 28 · see citing works
Zhao, L., He, Z., Zhang, D., Wang, G. T., Renton, A. E., Vardarajan, B. N., Nothnagel, M., Goate, A., Mayeux, R. P., & Leal, S. M. (2019) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2019.09.006 · Cited by 26 · see citing works
Nicolas, G., Zaréa, A., Lacour, M., Quenez, O., Rousseau, S., Richard, A., Bonnevalle, A., Schramm, C., Olaso, R., Sandron, F., et al. (2024) · Genetics in Medicine · doi:10.1016/j.gim.2024.101082 · Cited by 26 · see citing works
ABCA7, a Genetic Risk Factor Associated with Alzheimer’s Disease Risk in African Americans
Stepler, K. E., Gillyard, T. R., Reed, C. B., Avery, T. M., Davis, J. S., & Robinson, R. A. S. (2022) · Journal of Alzheimer s Disease · doi:10.3233/jad-215306 · Cited by 28 · see citing works
ABCA7 Regulates Brain Fatty Acid Metabolism During LPS-Induced Acute Inflammation
Aikawa, T., Ren, Y., Holm, M., Asmann, Y. W., Alam, A., Fitzgerald, M. L., Bu, G., & Kanekiyo, T. (2021) · Frontiers in Neuroscience · doi:10.3389/fnins.2021.647974 · Cited by 24 · see citing works
Ciani, M., Bonvicini, C., Scassellati, C., Carrara, M., Maj, C., Fostinelli, S., Binetti, G. G., Ghidoni, R., & Benussi, L. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20163903 · Cited by 23 · see citing works
ABCA7 and EphA1 Genes Polymorphisms in Late-Onset Alzheimer’s Disease
Talebi, M., Delpak, A., Khalaj-kondori, M., Sadigh‐Eteghad, S., Talebi, M., Mehdizadeh, E., & Majdi, A. (2019) · Journal of Molecular Neuroscience · doi:10.1007/s12031-019-01420-x · Cited by 23 · see citing works
High-density lipoprotein-related cholesterol metabolism in Alzheimer's disease
Pedrini, S., Chatterjee, P., Hone, E., & Martins, R. N. (2021) · Journal of Neurochemistry · doi:10.1111/jnc.15170 · Cited by 22 · see citing works
Bossaerts, L., Hens, E., Cacace, R., Asselbergh, B., & Broeckhoven, C. V. (2022) · Acta Neuropathologica Communications · doi:10.1186/s40478-022-01346-3 · Cited by 21 · see citing works
ABCA7-Associated Clinical Features and Molecular Mechanisms in Alzheimer’s Disease
Qian, X., Chen, S.-Y., Liu, X., & Tang, H.-D. (2023) · Molecular Neurobiology · doi:10.1007/s12035-023-03414-8 · Cited by 22 · see citing works
Vascular endothelial cells: a fundamental approach for brain waste clearance
Wei, H., Jiang, H., Zhou, Y., Xiao, X., Zhou, C., & Ji, X. (2022) · Brain · doi:10.1093/brain/awac495 · Cited by 20 · see citing works
Meta-Analysis of the Association between Variants in ABCA7 and Alzheimer’s Disease
Ma, F.-C., Wang, H.-F., Cao, X., Tan, C., Tan, L., & Yu, J. (2018) · Journal of Alzheimer s Disease · doi:10.3233/jad-180107 · Cited by 21 · see citing works
Jiao, B., Xiao, X., Yuan, Z., Guo, L., Liao, X., Zhou, Y., Zhou, L., Wang, X., Liu, X., Liu, H., et al. (2022) · Neuropsychopharmacology · doi:10.1038/s41386-021-01258-1 · Cited by 20 · see citing works
ABCA7 Genotypes Confer Alzheimer’s Disease Risk by Modulating Amyloid-β Pathology
Zhao, Q., Initiative, A. D. N., Wan, Y., Wang, H.-F., Sun, F.-R., Hao, X., Tan, M., Tan, C., Zhang, D., Tan, L., et al. (2016) · Journal of Alzheimer s Disease · doi:10.3233/jad-151005 · Cited by 20 · see citing works
Kunkle, B. W., Carney, R. M., Kohli, M. A., Naj, A. C., Hamilton-Nelson, K. L., Whitehead, P. L., Wang, L., Lang, R., Cuccaro, M. L., Vance, J. M., et al. (2017) · Neuroscience Letters · doi:10.1016/j.neulet.2017.04.014 · Cited by 19 · see citing works
Common and rare TBK1 variants in early-onset Alzheimer disease in a European cohort
Verheijen, J., van der Zee, J., Gijselinck, I., den Bossche, T. V., Dillen, L., Heeman, B., Gómez‐Tortosa, E., Lladó, A., Sánchez‐Valle, R., Graff, C., et al. (2017) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2017.10.012 · Cited by 19 · see citing works
Self-citationJayadev, S. (2022) · CONTINUUM Lifelong Learning in Neurology · doi:10.1212/con.0000000000001125 · Cited by 21 · see citing works
Rare <i>ABCA7</i> variants in 2 German families with Alzheimer disease
May, P., Pichler, S., Hartl, D., Bobbili, D. R., Mayhaus, M., Spaniol, C., Kurz, A., Balling, R., Schneider, J. G., & Riemenschneider, M. (2018) · Neurology Genetics · doi:10.1212/nxg.0000000000000224 · Cited by 18 · see citing works
Tayran, H., Yılmaz, E., Bhattarai, P., Min, Y.-H., Wang, X., Ma, Y.-Y., Wang, N., Jeong, I., Nelson, N., Kassara, N., et al. (2024) · Cell Genomics · doi:10.1016/j.xgen.2024.100642 · Cited by 17 · see citing works
The Abca7V1613M variant reduces Aβ generation, plaque load, and neuronal damage
Butler, C. A., Mendoza‐Arvilla, A., Milinkeviciute, G., Cunha, C. D., Kawauchi, S., Rezaie, N., Liang, H. Y., Javonillo, D. I., Thach, A., Wang, S., et al. (2024) · Alzheimer s & Dementia · doi:10.1002/alz.13783 · Cited by 14 · see citing works
Searching the Dark Genome for Alzheimer’s Disease Risk Variants
Raybould, R., & Sims, R. (2021) · Brain Sciences · doi:10.3390/brainsci11030332 · Cited by 17 · see citing works
Hoogmartens, J., Hens, E., Engelborghs, S., De Deyn, P. P., van der Zee, J., Van Broeckhoven, C., & Cacace, R. (2021) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2021.03.011 · Cited by 17 · see citing works
Self-citationBossaerts, L., Hens, E., Hanseeuw, B. J., Vandenberghe, R. R., Cras, P. P., Deyn, P. P. D., Engelborghs, S., & Broeckhoven, C. V. (2021) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2021.04.023 · Cited by 17 · see citing works
Self-citationPan, G., King, A. E., Wu, F., Simpson, S., Woodhouse, A., Phipps, A., & Vickers, J. C. (2021) · Ageing Research Reviews · doi:10.1016/j.arr.2021.101402 · Cited by 17 · see citing works
Whole‐exome rare‐variant analysis of Alzheimer's disease and related biomarker traits
Küçükali, F., Neumann, A., Dongen, J. V., Pooter, T. D., Joris, G., Rijk, P. D., Ohlei, O., Dobričić, V., Bos, I., Vos, S. J. B., et al. (2022) · Alzheimer s & Dementia · doi:10.1002/alz.12842 · Cited by 16 · see citing works
Self-citationStepler, K. E., & Robinson, R. A. S. (2019) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-05542-4_1 · Cited by 15 · see citing works
Clinical Deep Phenotyping of ABCA7 Mutation Carriers
Campbell, A. S., Ho, C. C. G., Atık, M., Allen, M., Lincoln, S., Malphrus, K., Nguyen, T., Oatman, S. R., Corda, M., Conway, O., et al. (2022) · Neurology Genetics · doi:10.1212/nxg.0000000000000655 · Cited by 14 · see citing works
An inclusive study of recent advancements in Alzheimer's disease: A comprehensive review
Singh, S., Mahajan, M., Kumar, D., Singh, K., Chowdhary, M., & Amit (2023) · Neuropeptides · doi:10.1016/j.npep.2023.102369 · Cited by 14 · see citing works
ABCA 7 and risk of dementia and vascular disease in the Danish population
Kjeldsen, E. W., Tybjærg‐Hansen, A., Nordestgaard, B. G., & Frikke‐Schmidt, R. (2017) · Annals of Clinical and Translational Neurology · doi:10.1002/acn3.506 · Cited by 14 · see citing works
Tosto, G., & Reitz, C. (2016) · Molecular and Cellular Probes · doi:10.1016/j.mcp.2016.09.001 · Cited by 14 · see citing works
EIF2AK3 variants in Dutch patients with Alzheimer's disease
Wong, T. H., van der Lee, S. J., van Rooij, J., Meeter, L. H. H., Frick, P., Melhem, S., Seelaar, H., Ikram, M. A., Rozemüller, A. J. M., Holstege, H. H., et al. (2018) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2018.08.016 · Cited by 14 · see citing works
Early‐onset Alzheimer's disease explained by polygenic risk of late‐onset disease?
Mantyh, W. G., Cochran, J. N., Taylor, J. W., Broce, I., Geier, E. G., Bonham, L. W., Anderson, A. G., Sirkis, D. W., Joie, R. L., Iaccarino, L., et al. (2023) · Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring · doi:10.1002/dad2.12482 · Cited by 12 · see citing works
Translating Alzheimer’s Disease Mechanisms into Therapeutic Opportunities
Li, J., Wang, L., Zhang, X., Shi, J., Zhu, Y. Z., Wang, H., Zhu, X., Zhu, Q., & Luo, J. (2025) · Biomolecules · doi:10.3390/biom15091290 · Cited by 12 · see citing works
- Authors
- Cuyvers, E., De Roeck, A., Van den Bossche, T., Van Cauwenberghe, C., Bettens, K., Vermeulen, S., Mattheijssens, M., Peeters, K., Engelborghs, S., Vandenbulcke, M., Vandenberghe, R., De Deyn, P. P., Van Broeckhoven, C., & Sleegers, K.
- Affiliations
- University of Antwerp (BE)
- Universitair Ziekenhuis Leuven (BE)
- Corresponding author
- Sleegers, Kristel
- Venue
- The Lancet Neurology
- Publisher
- Elsevier BV
- Published
- 2015-08
- Volume
- 14
- Issue
- 8
- Pages
- 814-822
- ISSN
- 1474-4422 (ISSN-L)
- OpenAlex
- W2168215272
- Cited by
- 152
- References
- 34
- Citations by year
- 2026: 3 · 2025: 8 · 2024: 15 · 2023: 8 · 2022: 17 · 2021: 11 · 2020: 15 · 2019: 12 · 2018: 16 · 2017: 20 · 2016: 22 · 2015: 4
- FWCI
- 15.20
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The Lancet Neurology (publishedVersion)
- PubMed (publishedVersion)
- Lirias (submittedVersion)
- VUBIR (Vrije Universiteit Brussel) (submittedVersion)
- Topics
- Health Sciences › Medicine › Physiology › Alzheimer's disease research and treatments
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic Associations and Epidemiology
- Keywords
- ABCA7, Alzheimer's disease, genetic risk variants, rare variants, founder effect, loss-of-function mutations, nonsense-mediated mRNA decay, Flanders, Alzheimer's disease pathogenesis, targeted sequencing, intronic variants, postmortem brain
- MeSH terms
- Aged, Aged, 80 and over, Alzheimer Disease, Belgium, Female, Gene Frequency, Humans, Male, Middle Aged, Mutation, Cohort Studies, Sequence Analysis, DNA, ATP-Binding Cassette Transporters, Polymorphism, Single Nucleotide, Genome-Wide Association Study
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
